Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

VRNAVRNA
Showing 6 of 14 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in VERONA PHARMA PLC

As of its Q3 2025 13F, Janus Henderson held 1,010,564 shares of VRNA (Verona Pharma), worth $107.8M. Janus Henderson's 13F filings listed VRNA from Q3 2022 to Q3 2025, 13 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$30M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Decreased
1M
-83.5%
$107.8M0.0%—
0
2025-Q2
Increased
6.1M
+11.2%
$580.1M0.3%—
42
2025-Q1
Increased
5.5M
+230.9%
$345.8M0.2%—
60
2024-Q4
Increased
1.7M
+59.9%
$77.5M0.0%—
43
2024-Q3
Decreased
1M
-4.5%
$30M0.0%—
0

Other major holders of VRNA: Pentwater Capital Management LP, HBK INVESTMENTS L P, BlackRock, Inc., FIL Ltd, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used